|
Feinberg experienced a year of outstanding growth, scientific achievement, and collaboration in 2023, from honors and awards to unprecedented research discoveries. Explore a selection of the most impactful and groundbreaking stories from last year. Read more » |
Northwestern Medicine investigators have successfully localized novel molecular mechanisms behind a genetic mutation found in a wide range of cancers, which could serve as a biomarker for improving patient stratification and treatment. Read more »
| |
Two years after the FDA’s approval of semaglutide for chronic weight management, Northwestern Medicine scientists remain at the forefront of investigating the drug’s potential in helping patients who are overweight or have obesity who also have other preexisting health conditions. Read more »
| |
Northwestern Medicine investigators have discovered that specialized immune cells within the glioblastoma tumor microenvironment use a unique “feeding” mechanism that promotes tumor growth and treatment resistance. Read more »
| |
The largest one-time gift to Northwestern Medicine will establish a new cancer institute in Orland Park. Read more »
| |
Kathie Schultz had stage 3 lung cancer before becoming the first patient at Northwestern Medicine to undergo the innovative procedure. Read more »
| |
Have an idea for the newsletter or a comment on this issue? Contact Us » |
|